What question did this study set out to answer?

Evaluate the effectiveness of chitosan and polycaprolactone coatings on magnetic elastomers' biocompatibility.

February 14, 2026Scientific Reports0 citationsOpen Access

Chitosan and polycaprolactone blended PDMS coatings improve biocompatibility of magnetic elastomers

JMJoanna MystkowskaBialystok University of Technology DŁDawid Łysik ACAnna CzerniakiewiczBialystok University of Technology

Key Points

Evaluate the effectiveness of chitosan and polycaprolactone coatings on magnetic elastomers' biocompatibility.
Developed spin-coated PDMS-chitosan and PDMS-polycaprolactone coatings
Conducted immersion tests over 24 weeks to assess ion release
Performed biological validation with fibroblasts and erythrocytes
Coatings reduced neodymium and iron release by over 95%
PDMS-PCL coatings preserved magnetorheological actuation comparable to uncoated composites
Coatings exhibited cytocompatibility and hemocompatibility, suppressing bacterial biofilm formation

Abstract

PDMS/NdFeB composites are promising materials for soft magnetic actuators, but NdFeB particles corrode in body fluids and release toxic metal ions, limiting their biomedical use. We developed ~ 100 µm spin-coated PDMS-chitosan (PDMS-CHIT) and PDMS-polycaprolactone (PDMS-PCL) coatings that solve this problem. Over 24 weeks of immersion, these coatings reduced neodymium and iron release by more than 95%, keeping ion concentrations well below cytotoxicity thresholds. Importantly, the PDMS-PCL coating fully preserved magnetorheological actuation (ΔG’ ≈ 61 kPa under 0.5 T, comparable to uncoated composite), while PDMS-CHIT provided superior ion barrier at the cost of reduced actuation force. Biological validation confirmed cytocompatibility with fibroblasts, hemocompatibility with erythrocytes, and strong suppression of bacterial biofilm formation. These results establish a validated materials platform for biocompatible soft magnetic actuators.

Ask AI

Helpful

Bookmark

View Full Paper